$23.92
-0.94-3.78%
SpyGlass Pharma Inc
SGPNASDAQ
SpyGlass Pharma (SGP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.53 | $-0.42 | — |
| Actual | $-0.59 | $-0.69 | $-5.72 |
| Surprise | -11.3% | -64.3% | — |
| Revenue | |||
| Estimate | — | — | — |
| Actual | $0 | $0 | $0 |
| Surprise | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.63 | $-0.66 | $-0.67 | $-0.69 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.59 | $-0.53 | -11.3 % |
| Q1 | May 14, 2026 | $-0.69 | $-0.42 | -64.3 % |
